We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Commercial Kit Enables Rapid Assessment of Chromatin Structure

By LabMedica International staff writers
Posted on 13 Feb 2011
A commercial kit is now available that enables the rapid quantitative assessment of chromatin structure by quantitatively differentiating expressed (accessible) and silent (inaccessible) regions of the genome.

The Bio-Rad Laboratories (Hercules, CA, USA) EpiQ chromatin analysis kit was designed to complement existing epigenetic assays such as DNA methylation and chromatin immunoprecipitation. More...
These measurements detect whether epigenetic processes such as DNA methylation or histone modification have caused changes in gene expression.

The EpiQ chromatin analysis kit was designed to differentiate between genes that are being actively transcribed (euchromatin) and silent genes (heterochromatin). The selective nuclease provided in the kit can only act on euchromatin. The difference in the amount of DNA detected by the kit's PCR reagents before and after nuclease digestion reveals the extent to which the target gene is expressed.

The EpiQ kit includes buffers for cell permeabilization and in situ chromatin digestion, optimized nuclease, materials for genomic DNA purification, control assays (qPCR primers) for chromatin assessment of a reference (epigenetically silenced) and control (constitutively expressed) gene, and EpiQ Chromatin SYBR Green Supermix, a real-time PCR reagent designed to amplify genomic DNA.

The EpiQ kit permits assessment of chromatin structure in as few as 50,000 cultured cells within six hours, and it can generate quantitative chromatin structure information for multiple genomic elements.

"The EpiQ chromatin analysis kit provides researchers with an easy and fast way to quantify a gene's chromatin state,” said Viresh Patel, marketing manager for PCR reagents at Bio-Rad. "Using the kit, cancer, developmental, and stem cell biology researchers are able to glean direct information regarding the chromatin state that is associated with epigenetic marks such as DNA methylation and histone modifications for the first time."

Related Links:
Bio-Rad Laboratories



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
Portable POCT Blood Gas Analyzer
BD100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.